Using lipid nanoparticles and messenger RNA to treat blindness associated with rare genetic condition

Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

Oregon State University College of Pharmacy scientists have demonstrated in animal models the possibility of using lipid nanoparticles and messenger RNA, the technology underpinning COVID-19 vaccines, to treat blindness associated with a rare genetic condition.

Expert Tips for Using the Ozempic Pen Injection Correctly

Previous article

Study analyzes the viability of new nanomolecule as drug delivery vehicle

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News